DexCom (DXCM) on Monday reported preliminary, unaudited results for the fourth quarter ended December 31, 2025 with total revenue of approximately $1.26 billion, up 13% from a year earlier.  U.S.

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...

DexCom will release its fourth-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession ...

Leinster boss Leo Cullen says they will have a clearer picture on Monday of injuries picked up by Ireland players Tadhg ...

With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...

Tadhg Furlong, RG Snyman and Garry Ringrose among them – return from varying lengths of injury-enforced absences.

There are exciting advancements in patient standard of care thanks to continuous health monitoring technologies.

Withings has partnered with Abbott's Lingo CGM to bring glucose monitoring to 15 million users starting Q1 2026 for metabolic ...

Wall ‍Street's main ​indexes opened lower ⁠on Monday after the Trump administration renewed ‌its attacks ‌on the Federal Reserve, ‌stoking fresh worries about the central bank's independence, while a ...

The Trump administration is reportedly threatening criminal charges against Federal Reserve Chair Jerome Powell over ...